30.06.2010
- Sanofi-Aventis is to buy U.S. biotech TargeGen, which is developing treatments against blood diseases, for as much as $560 million as part of the French drugmaker's drive to boost...
18.06.2010
- Amgen is "aggressively" looking at acquisitions, particularly opportunities for international expansion, Chief Executive Kevin Sharer said in a webcast presentation on Thursday....
12.05.2010
- Merck & Co plans to seek approval for five new medicines this year, including a closely watched hepatitis C treatment, but has halted development of an experimental anemia medicine...
05.05.2010
- Anglo-Swedish drugmaker Astrazeneca is aggressively meeting potential acquisition partners to fill as it prepares for generic competition from some of its best-selling drugs. "We...
27.04.2010
- Amgen, the world's largest biotechnology company, said on Monday its chief financial officer, Robert Bradway, has been named president and chief operating officer of the company...
31.03.2010
- French drugmaker Sanofi-Aventis on Wednesday said it would invest €150 million over four years to build up its biotechnology manufacturing capacities in France. The project aims at...
05.03.2010
- Global pharmaceutical and chemical company Merck KGaA headquartered in Darmstadt, Germany, will acquire Millipore Corporation, a leading Life Science company based in Billerica, U...
02.03.2010
- Germany's family-controlled Merck KGaA agreed to buy U.S. biotech tool maker Millipore for $6 billion to diversify away from its embattled drugs business. While analysts said the...
